...
首页> 外文期刊>The Veterinary Journal >Evaluation of a technique to measure heart rate variability in anaesthetised cats
【24h】

Evaluation of a technique to measure heart rate variability in anaesthetised cats

机译:评估麻醉猫心率变异性的技术的评估

获取原文
获取原文并翻译 | 示例

摘要

Analysis of heart rate (HR) and heart rate variability (HRV) are powerful tools to investigate cardiac diseases, but current methods, including 24-h Halter monitoring, can be cumbersome and may be compromised by movement artefact. A commercially available data capture and analysis system was used in anaesthetised healthy cats to measure HR and HRV during pharmacological manipulation of HR. Seven healthy cats were subjected to a randomised crossover study design with a 7 day washout period between two treatment groups, placebo and atenolol (1 mg/kg, IV), with the efficacy of atenolol to inhibit beta(1) adrenoreceptors challenged by epinephrine. Statistical significance for the epinephrine challenge was set at P < 0.0027 (Holm-Bonferroni correction), whereas a level of significance of P < 0.05 was set for other variables. Analysis of the continuous electrocardiography (ECG) recordings showed that epinephrine challenge increased HR in the placebo group (P = 0.0003) but not in the atenolol group. The change in HR was greater in the placebo group than in the atenolol group (P = 0.0004). Therefore, compared to cats pre-treated with placebo, pre-treatment with atenolol significantly antagonised the tachycardia while not significantly affecting HRV. The increased HR in the placebo group following epinephrine challenge was consistent with a shift of the sympathovagal balance towards a predominantly sympathetic tone. However, the small (but not significant at the critical value) decrease in the normalised high-frequency component (HFnorm) in both groups of cats suggested that epinephrine induced a parasympathetic withdrawal in addition to sympathetic enhancement (increased normalised low frequency component or LFnorm). In conclusion, this model is a highly sensitive and repeatable model to investigate HRV in anaesthetised cats that would be useful in the laboratory setting for short-term investigation of cardiovascular disease and subtle responses to pharmacological agents in this species
机译:心率(HR)和心率变异性(HRV)的分析是研究心脏病的有力工具,但是当前的方法(包括24小时Halter监测)可能很麻烦,并且可能会因运动伪影而受损。在麻醉的健康猫中使用可商购的数据捕获和分析系统,以在HR进行药理处理时测量HR和HRV。对七只健康的猫进行了随机交叉研究设计,在两个治疗组安慰剂和阿替洛尔(1 mg / kg,IV)之间进行了7天的洗脱期,阿替洛尔具有抑制肾上腺素激发的β(1)肾上腺素受体的功效。肾上腺素激发的统计学显着性设定为P <0.0027(霍姆-邦费罗尼校正),而其他变量的显着性水平设定为P <0.05。连续心电图(ECG)记录的分析表明,肾上腺素激发使安慰剂组的HR增加(P = 0.0003),但阿替洛尔组却没有。安慰剂组的HR变化大于阿替洛尔组(P = 0.0004)。因此,与用安慰剂预处理的猫相比,用阿替洛尔预处理可以显着拮抗心动过速,而不会显着影响HRV。肾上腺素攻击后,安慰剂组的HR升高与交感神经平衡向主要交感神经的转变相一致。但是,两组猫的归一化高频成分(HFnorm)都有小幅下降(但在临界值处并不显着),这表明肾上腺素除了引起交感增强外还引起副交感神经退缩(归一化低频分量或LFnorm增加) 。总之,该模型是一种高度敏感且可重复的模型,可用于研究麻醉猫的HRV,可用于实验室环境中的心血管疾病短期调查以及对该物种药理作用的微妙反应

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号